[MIRM]

Mid 2026-10-12 23:26:47

Mirum's Livmarli meets primary goal in phase 3 trial for itch with rare liver diseases

Row 2026-10-12 06:23:05

Mirum Pharmaceuticals to share phase 3 LIVMARLI study results

Mid 2026-09-29 00:46:42

Mirum falls despite meeting primary goal in phase 3 brelovitug study for hepatitis D

Mid 2026-09-28 06:09:38

Mirum to present phase 3 hepatitis delta study results Monday

Mid 2026-09-26 22:58:38

Mirum and Incyte gain approval of zilurgisertib for rare bone disorder